TY - JOUR
T1 - Monitoring MCS patients on the intensive care unit
T2 - integrating haemodynamic assessment, laboratory data, and imaging techniques for timely detection of deterioration and recovery
AU - Vandenbriele, Christophe
AU - Baldetti, Luca
AU - Beneduce, Alessandro
AU - Belohlavek, Jan
AU - Hassager, Christian
AU - Pieri, Marina
AU - Polzin, Amin
AU - Scandroglio, Anna Mara
AU - Møller, Jacob Eifer
N1 - © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.
PY - 2023/12
Y1 - 2023/12
N2 - Monitoring of the patient supported with a temporary mechanical circulatory support (tMCS) is crucial in achieving the best possible outcome. Monitoring is a continuous and labour-intensive process, as cardiogenic shock (CS) patients can rapidly deteriorate and may require new interventions within a short time period. Echocardiography and invasive haemodynamic monitoring form the cornerstone of successful tMCS support. During monitoring, it is particularly important to ensure that adequate end-organ perfusion is achieved and maintained. Here, we provide a comprehensive overview of best practices for monitoring the CS patient supported by a micro-axial flow pump, veno-arterial extracorporeal membrane oxygenation, and both devices simultaneously (ECMELLA approach). It is a complex process that encompasses device control, haemodynamic control and stabilization, monitoring of interventions, and assessment of end-organ function. The combined, continuous, and preferably protocol-based approach of echocardiography, evaluation of biomarkers, end-organ assessment, and haemodynamic parameters is crucial in assessing this critically ill CS patient population.
AB - Monitoring of the patient supported with a temporary mechanical circulatory support (tMCS) is crucial in achieving the best possible outcome. Monitoring is a continuous and labour-intensive process, as cardiogenic shock (CS) patients can rapidly deteriorate and may require new interventions within a short time period. Echocardiography and invasive haemodynamic monitoring form the cornerstone of successful tMCS support. During monitoring, it is particularly important to ensure that adequate end-organ perfusion is achieved and maintained. Here, we provide a comprehensive overview of best practices for monitoring the CS patient supported by a micro-axial flow pump, veno-arterial extracorporeal membrane oxygenation, and both devices simultaneously (ECMELLA approach). It is a complex process that encompasses device control, haemodynamic control and stabilization, monitoring of interventions, and assessment of end-organ function. The combined, continuous, and preferably protocol-based approach of echocardiography, evaluation of biomarkers, end-organ assessment, and haemodynamic parameters is crucial in assessing this critically ill CS patient population.
KW - ECMELLA
KW - ICU management
KW - Micro-Axial flow pump
KW - Monitoring
KW - V-A ECMO
UR - http://www.scopus.com/inward/record.url?scp=85180285453&partnerID=8YFLogxK
U2 - 10.1093/eurheartjsupp/suad130
DO - 10.1093/eurheartjsupp/suad130
M3 - Journal article
C2 - 38093766
SN - 1520-765X
VL - 25
SP - I24-I31
JO - European heart journal supplements : journal of the European Society of Cardiology
JF - European heart journal supplements : journal of the European Society of Cardiology
IS - Suppl I
ER -